Cargando…

Tissue transglutaminase in the pathogenesis of heart failure

Detalles Bibliográficos
Autores principales:	Shinde, Arti V., Frangogiannis, Nikolaos G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5864221/ https://www.ncbi.nlm.nih.gov/pubmed/29238072 http://dx.doi.org/10.1038/s41418-017-0028-9

Ejemplares similares

The Role of Macrophages in Nonischemic Heart Failure
por: Chen, Bijun, et al.
Publicado: (2018)

Smad7 effects on TGF-β and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure
por: Humeres, Claudio, et al.
Publicado: (2022)

Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
por: Hanna, Anis, et al.
Publicado: (2020)

Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin
por: GAO, HAI-CHENG, et al.
Publicado: (2015)

Transforming growth factor–β in tissue fibrosis
por: Frangogiannis, Nikolaos G.
Publicado: (2020)

Pericytes in the infarcted heart
por: Alex, Linda, et al.
Publicado: (2019)

Optimal screening of heart failure patients: tissue Doppler imaging or plasma NTpro BNP measurement?
por: Baur, Leo H. B.
Publicado: (2008)

Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure
por: Liang, Bo, et al.
Publicado: (2022)

Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure
por: Sakai, Kotomi, et al.
Publicado: (2022)

Fibroblasts in the Infarcted, Remodeling, and Failing Heart
por: Humeres, Claudio, et al.
Publicado: (2019)

Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?
por: Mann, Douglas L., et al.
Publicado: (2017)

Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

The Importance of PTH for Heart Failure. Comment on Thiele et al. The Role of Vitamin D(3) as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure. J. Clin. Med. 2022, 11, 2733
por: Grant, William B., et al.
Publicado: (2022)

Ophthalmic complications of dengue: pathogenesis and prevention
por: Uma, Alagappan, et al.
Publicado: (2013)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

A Growth Tonic for Heart Failure?
por: Bishopric, Nanette H.
Publicado: (2016)

Tryptophan: ‘essential’ for the pathogenesis of irritable bowel syndrome?
por: Berstad, Arnold, et al.
Publicado: (2014)

Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failure
por: Packer, Milton
Publicado: (2023)

Reconsidering Renal Sympathetic Denervation for Heart Failure
por: Tang, W.H. Wilson, et al.
Publicado: (2017)

Brain-derived neurotrophic factor in heart failure
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Oxytocin: A New Therapeutic for Heart Failure?
por: Habecker, Beth A.
Publicado: (2020)

Tracing triggers of cardiac remodelling and heart failure
por: van Driel, B. O., et al.
Publicado: (2021)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)

The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention
por: Vespasiani-Gentilucci, Umberto, et al.
Publicado: (2016)

Blood clots and TAM receptor signalling in COVID-19 pathogenesis
por: Lemke, Greg, et al.
Publicado: (2020)

Metabolic Coupling as a Therapeutic Strategy for Heart Failure
por: Young, Martin E.
Publicado: (2019)

Association of Anti-tissue Transglutaminase Antibody Titers and Duodenal Biopsy Findings in Pediatric Patients of Celiac Disease
por: Taneja, Kanchan, et al.
Publicado: (2021)

Muscular Dystrophy Meets the Gene Chip: New Insights into Disease Pathogenesis
por: Chamberlain, Jeffrey S.
Publicado: (2000)

Biodiversity and its double-edged role in the pathogenesis of type 1 diabetes
por: Chan, Daniel, et al.
Publicado: (2023)

Abnormal heart rate recovery in patients with heart failure: an important target for exercise training treatment
por: Dimopoulos, Stavros
Publicado: (2015)

Exercise, Vascular Stiffness, and Tissue Transglutaminase
por: Steppan, Jochen, et al.
Publicado: (2014)

Transglutaminases Are Active in Perivascular Adipose Tissue
por: Orr, Alexis N., et al.
Publicado: (2021)

The Outside-In Journey of Tissue Transglutaminase in Cancer
por: Sima, Livia Elena, et al.
Publicado: (2022)

Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan
por: Yui, Yoshiki
Publicado: (2018)

Beyond lipid lowering: pleiotropic effects of statins in heart failure
por: Swenne, C. A.
Publicado: (2013)

Cardiometabolic Heart Failure and HFpEF: Still Chasing Unicorns
por: Sharp, Thomas E., et al.
Publicado: (2019)

Targeting Mitochondrial Function in Heart Failure: Makes Sense But Will it Work?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2019)

Modulation of Glucagon Signaling: A Metabolic Approach for Heart Failure?
por: Pocai, Alessandro
Publicado: (2019)

Promoting Health Equity in Heart Failure Amid a Pandemic
por: DeFilippis, Ersilia M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ma07f0aisrolrvhcnieu60ed4d